Dietrich A. Stephan
Dr. Dietrich A. Stephan is the CEO, Chairman, and Founder of NeuBase Therapeutics, which is developing a new class of precision genetic medicines to address rare and common diseases at the base level. At NeuBase, he brings his deep expertise in genetic diseases, personalized medicine, and first-in-class therapeutic development to redefine medicine for millions of patients with limited treatment options. Dr. Stephan identified the molecular basis of dozens of rare and common diseases published extensively in journals and has helped launch 14 biotechnology companies to advance novel molecular diagnostics and first-in-class therapeutics to market. These companies include Navigenics, Pendulum, and Peptilogics. Dietrich remains inspired by the army of scientists and biotechnologists who battle daily for the lives of those suffering and dying needlessly from disease.
-
MedCity Influencers, BioPharma
How to navigate the biotech investment downturn: Get back to basics
There is no arguing that the last year has been a rocky one for biotech companies, but trends suggest that the sector is ready for an upswing. The revenue model works, innovation continues to bear fruit, and the need is ever-present. The harsh winter will result in a hearty harvest.
-
MedCity Influencers, BioPharma, Health Tech
The new paradigm in drug development: Why platform technology is the solution patients and payers need
The model of investing huge amounts of money into one drug to try to recoup it later is problematic at best and unsustainable at worst. Platform technology provides a better, more cost-effective way forward.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
